Mr. Van Naarden serves as an Analyst of Aisling Capital. Previously, Mr. Van Naarden was an Analyst in the Healthcare Group of Goldman Sachs’s Investment Banking Division, where he worked closely with management of companies across the worldwide healthcare industry, primarily in pharmaceuticals and biotechnology, in the evaluation and execution of acquisitions, financings, and corporate strategy.

Mr. Van Naarden received his A.B. from Princeton University, awarded Phi Beta Kappa and magna cum laude in molecular biology.

Dennis Purcell
Steven A. Elms
Andrew Schiff
Dov A. Goldstein
Anthony Y. Sun
Brett I.W. Zbar
Josh Bilenker
Aftab R. Kherani
Stacey D. Seltzer
Christine Lee Ha
Justin Sun
Jacob Van Naarden
Lloyd E. Appel
Andrew P. Nicholson
Robert J. Wenzel
Diana Robinson
Jan Hoerrner